Literature DB >> 10580422

A critical role for human CD4+ T-cells in rejection of porcine islet cell xenografts.

T Friedman1, R N Smith, R B Colvin, J Iacomini.   

Abstract

T-cell-mediated rejection is likely to present a significant barrier to porcine islet xenotransplantation. Little is known, however, about human anti-porcine islet rejection because no suitable model exists to study this process. To address this problem, we have developed an immunodeficient mouse model to study rejection of fetal porcine islet cell clusters (ICCs) by human lymphocytes. Transplantation of porcine ICCs into hyperglycemic recombinase activating gene-deficient (R-) mice restores normal blood glucose levels within 5 weeks. Adoptive transfer of in vitro-stimulated human peripheral blood mononuclear cells into R- mice before islet cell transplantation leads to acute cellular rejection of porcine ICCs. The first human cells observed to infiltrate rejecting grafts are CD4+ T-cells. Although CD8+ T-cells are observed within the grafts at later time points, CD4+ T-cells predominate until the graft is destroyed. Adoptive transfer of purified human CD4+ T-cells before ICC transplantation is sufficient to cause acute cellular rejection. These data demonstrate that human CD4+ T-cells play a critical role in porcine ICC xenograft rejection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580422     DOI: 10.2337/diabetes.48.12.2340

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

Review 1.  Transplantation of xenogeneic islets: are we there yet?

Authors:  Philip J O'Connell; Peter J Cowan; Wayne J Hawthorne; Shounan Yi; Andrew M Lew
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

2.  CD4 T cells mediate cardiac xenograft rejection via host MHC Class II.

Authors:  Robert J Plenter; Todd J Grazia; An N Doan; Ronald G Gill; Biagio A Pietra
Journal:  J Heart Lung Transplant       Date:  2012-07-11       Impact factor: 10.247

3.  Immune rejection after pancreatic islet cell transplantation: in vivo dual contrast-enhanced MR imaging in a mouse model.

Authors:  Ping Wang; Christian Schuetz; Alana Ross; Guangping Dai; James F Markmann; Anna Moore
Journal:  Radiology       Date:  2012-12-21       Impact factor: 11.105

4.  Effects of streptozotocin on autoimmune diabetes in NOD mice.

Authors:  M Koulmanda; A Qipo; H Auchincloss; R N Smith
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

5.  Adoptive transfer with in vitro expanded human regulatory T cells protects against porcine islet xenograft rejection via interleukin-10 in humanized mice.

Authors:  Shounan Yi; Ming Ji; Jingjing Wu; Xiaoqian Ma; Peta Phillips; Wayne J Hawthorne; Philip J O'Connell
Journal:  Diabetes       Date:  2012-03-08       Impact factor: 9.461

6.  Transient B-cell depletion combined with apoptotic donor splenocytes induces xeno-specific T- and B-cell tolerance to islet xenografts.

Authors:  Shusen Wang; James Tasch; Taba Kheradmand; Jodie Ulaszek; Sora Ely; Xiaomin Zhang; Bernhard J Hering; Stephen D Miller; Xunrong Luo
Journal:  Diabetes       Date:  2013-07-12       Impact factor: 9.461

7.  A preclinical evaluation of alternative site for islet allotransplantation.

Authors:  Chengshi Wang; Xiaojiong Du; Sirong He; Yujia Yuan; Pengfei Han; Dan Wang; Younan Chen; Jingping Liu; Bole Tian; Guang Yang; Shounan Yi; Fabao Gao; Zhihui Zhong; Hongxia Li; Jingqiu Cheng; Yanrong Lu
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

Review 8.  Cellular Immune Responses in Islet Xenograft Rejection.

Authors:  Min Hu; Wayne J Hawthorne; Shounan Yi; Philip J O'Connell
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

9.  Survival of free and encapsulated human and rat islet xenografts transplanted into the mouse bone marrow.

Authors:  Raphael P H Meier; Jörg D Seebach; Philippe Morel; Redouan Mahou; Sophie Borot; Laurianne Giovannoni; Geraldine Parnaud; Elisa Montanari; Domenico Bosco; Christine Wandrey; Thierry Berney; Leo H Bühler; Yannick D Muller
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.